The S&P/ASX Small Ordinaries Index [XSO] rose 103.40 points or 3.18% over the past five days, closing at 3,352.80 on Friday. The gain comes as several small-cap companies reported operational and strategic updates. It has been a solid start to the week on the news front already, and you can read about the following and more throughout the day.
Tryp Therapeutics begins BED trial
Tryptamine Therapeutics Ltd (ASX:TYP, OTC:TYPTF) has started patient recruitment in its world-first clinical trial using TRP-8803 to treat Binge Eating Disorder (BED), in collaboration with Swinburne University.
Pantoro Gold hits upper-end of production guidance
Pantoro Gold Ltd (ASX:PNR, OTC:PNTOD) produced 25,417 ounces of gold for the June quarter at its Norseman Gold Project in Western Australia. The company reported A$43.3 million in cash and gold build, EBITDA of A$80.4 million, and an all-in sustaining cost of A$1,991 per ounce. Annual EBITDA reached A$196.4 million.
Resolution strengthens US critical minerals push
Resolution Minerals Ltd (ASX:RML, OTC:RLMLF) appointed mining executives Steve Promnitz and Brett Lynch as Senior Strategic Advisers to lead its go-to-market strategy in the United States critical minerals sector.
Nova ramps up drilling at RPM in Alaska
Nova Minerals Ltd (ASX:NVA, NASDAQ:NVA, OTC:NVAAF) has begun its 2025 drilling campaign at the high-grade RPM deposit in Alaska, with two diamond drill rigs and one reverse circulation rig in operation. Initial geological observations are encouraging, with assay results expected in coming months.
Lumos Diagnostics advances FebriDx study
Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF)reported unaudited FY25 revenue of US$12.4 million, up 12% year-on-year. Fourth-quarter revenue declined due to the end of the US flu season, while the FebriDx CLIA Waiver Study nears completion, with a US Food and Drug Administration (FDA) submission anticipated within three months.
Firebird Metals expands IP protection in China
Firebird Metals Ltd (ASX:FRB, OTC:FRBMF) secured two patent grants and advanced four additional applications in China for its lithium manganese iron phosphate (LMFP) cathode materials. The patents cover innovations from precursor design to final cathode structures.
Elixir Energy prepares for drilling campaign
Elixir Energy Ltd (ASX:EXR, OTC:ELXPF) ended the quarter with A$10.4 million in cash and receivables and is funded for Phase 1 of its three-phase strategic plan. Preparations are underway for a two-well campaign in the Taroom Trough, Queensland, starting with the Diona-1 exploration well.